HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

Abstract
Life-threatening graft-versus-host disease (GVHD) limits the use of HLA-C-mismatched unrelated donors in transplantation. Clinicians lack criteria for donor selection when HLA-C-mismatched donors are a patient's only option for cure. We examined the role for HLA-C expression levels to identify permissible HLA-C mismatches. The median fluorescence intensity, a proxy of HLA-C expression, was assigned to each HLA-C allotype in 1975 patients and their HLA-C-mismatched unrelated transplant donors. The association of outcome with the level of expression of patients' and donors' HLA-C allotypes was evaluated in multivariable models. Increasing expression level of the patient's mismatched HLA-C allotype was associated with increased risks of grades III to IV acute GVHD, nonrelapse mortality, and mortality. Increasing expression level among HLA-C mismatches with residue 116 or residue 77/80 mismatching was associated with increased nonrelapse mortality. The immunogenicity of HLA-C mismatches in unrelated donor transplantation is influenced by the expression level of the patient's mismatched HLA-C allotype. HLA-C expression levels provide new information on mismatches that should be avoided and extend understanding of HLA-C-mediated immune responses in human disease.
AuthorsEffie W Petersdorf, Theodore A Gooley, Mari Malkki, Andrea P Bacigalupo, Anne Cesbron, Ernette Du Toit, Gerhard Ehninger, Torstein Egeland, Gottfried F Fischer, Thibaut Gervais, Michael D Haagenson, Mary M Horowitz, Katharine Hsu, Pavel Jindra, Alejandro Madrigal, Machteld Oudshoorn, Olle Ringdén, Marlis L Schroeder, Stephen R Spellman, Jean-Marie Tiercy, Andrea Velardi, Campbell S Witt, Colm O'Huigin, Richard Apps, Mary Carrington, International Histocompatibility Working Group in Hematopoietic Cell Transplantation
JournalBlood (Blood) Vol. 124 Issue 26 Pg. 3996-4003 (Dec 18 2014) ISSN: 1528-0020 [Electronic] United States
PMID25323824 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright© 2014 by The American Society of Hematology.
Chemical References
  • HLA-C Antigens
Topics
  • Adolescent
  • Adult
  • Aged
  • Alleles
  • Female
  • Graft vs Host Disease
  • HLA-C Antigens (metabolism)
  • Hematopoietic Stem Cell Transplantation
  • Histocompatibility (immunology)
  • Humans
  • Leukemia (immunology, therapy)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myelodysplastic Syndromes (immunology, therapy)
  • Retrospective Studies
  • Treatment Outcome
  • Unrelated Donors
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: